Patrick Lin Insider Trades & Stock Holdings

Chief Business - Strategy Off · Processa Pharmaceuticals, Inc. · Latest filing Jun 15, 2026

Patrick Lin, Chief Business - Strategy Off at Processa Pharmaceuticals, Inc. has 2 Form 4 trades on file since Jun 15, 2026. Open-market activity: 2 purchases ($8.13K) and 0 sales ($0), net +$8.13K. Latest filing: acquired 1.83K shares of $PCSA on Jun 15, 2026 at $2.22.

Trades on file

2

Open-market bought

$8.13K

Open-market sold

$0

Net open-market

+$8.13K

Latest filing

Jun 15, 2026

All insider trades by Patrick Lin

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 15, 2026	$PCSA	Buy (Open-market buy)	1.83K	$2.22	$4.06K			-5.9%	+8.1%		Chief Business - Strategy Off		Read
Jun 15, 2026	$PCSA	Buy (Open-market buy)	1.83K	$2.22	$4.06K			-5.9%	+8.1%		Chief Business - Strategy Off		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Patrick Lin traded

• $PCSA

Frequently asked questions

Has Patrick Lin been buying or selling stock?

Patrick Lin has 2 open-market purchases and 0 open-market sales on file, net +$8.13K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Patrick Lin's latest insider trade?

acquired 1.83K shares of $PCSA on Jun 15, 2026 at $2.22.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.